Immunome's chart data is dated 2026-10-08. There is no active technical signal. There are 5 published signal records.
Immunome last closed at $19.31 (+1.13%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -8.6×. Its overall grade ranks 363 of 738 stocks in Healthcare.
About this company
Immunome last closed at $19.31 (+1.13%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 363/738
Valuation grade A
Related stocks
- AbbVieCompetitor
항체·항암 치료제 포트폴리오를 가진 대형 바이오 제약사
- AmgenCompetitor
항체 기반 항암·면역 치료제 개발 경쟁사
- GenmabCompetitor
항체/면역항암제 개발에서 경쟁하는 바이오테크
ETFs holding this stock
WisdomTree BioRevolution Fund
Details →About Immunome
- What technical signals does Immunome (IMNM) have?
- Immunome current technical signals: no active technical signal.
- Is Immunome a cup-and-handle pattern?
- No. Immunome has no valid Cup signal right now.
- What published figures are available for Immunome?
- Market cap: $2.13B. Trailing 12 months PER: -8.6×. Latest quarter PBR: 4.17×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Immunome, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.